Karyopharm Therapeutics, Inc. (KPTI)
6.42
+0.53
(+9.00%)
USD |
NASDAQ |
Dec 09, 16:00
6.42
0.00 (0.00%)
After-Hours: 20:00
Karyopharm Therapeutics EPS Diluted (Quarterly): -3.821 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| TG Therapeutics, Inc. | 2.428 |
| Actinium Pharmaceuticals, Inc. | -0.1645 |
| Axsome Therapeutics, Inc. | -0.9442 |
| Krystal Biotech, Inc. | 2.660 |
| Akebia Therapeutics, Inc. | 0.002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -33.13M |
| Revenue (Quarterly) | 44.04M |
| Total Expenses (Quarterly) | 77.17M |
| Enterprise Value | 250.98M |
| Gross Profit Margin (Quarterly) | 94.93% |
| Profit Margin (Quarterly) | -75.21% |
| Earnings Yield | -227.1% |
| Normalized Earnings Yield | -227.11 |